Hemodynamic and Neurohormonal Predictors and Consequences of the Development of Atrial Fibrillation in Dogs With Chronic Heart Failure

Journal of Cardiac Failure

Volumn 12, Issue 9, 2006, Pages 747-751

  Tisdale, James E ^a,b   Borzak, Steven ^c   Sabbah, Hani N ^c   Shimoyama, Hisashi ^c   Goldstein, Sidney ^c  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

^c HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

Cardiac output; Left ventricular ejection fraction; Plasma norepinephrine concentrations; Plasma renin activity

Indexed keywords

NEUROHORMONE; NORADRENALIN; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL EMBOLISM; CONTROLLED STUDY; DISEASE COURSE; DOG; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HEART VENTRICLE ENDDIASTOLIC PRESSURE; LUNG WEDGE PRESSURE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINUS RHYTHM;

ANIMALS; ATRIAL FIBRILLATION; BLOOD PRESSURE; CARDIAC OUTPUT; CARDIAC OUTPUT, LOW; CARDIOVASCULAR SYSTEM; CHRONIC DISEASE; DOGS; NOREPINEPHRINE; PULMONARY WEDGE PRESSURE; RENIN; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 33845382308     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2006.08.005     Document Type: Article

References (37)

1. Kannel W.B., Abbott R.D., Savage D.D., and McNamara P.M. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306 (1982) 1018-1022
2. Benjamin E.J., Levy D., Vaziri S.M., D'Agostino R.B., Belanger A.J., and Wolf P.A. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271 (1994) 840-844
3. Feinberg W.M., Blackshear J.L., Laupacis A., Kronmal R., and Hart R.G. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 155 (1995) 469-473
4. Krahn A.D., Manfreda J., Tate R.B., Mathewson F.A., and Cuddy T.E. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 98 (1995) 476-484
5. Middlekauff H.R., Stevenson W.G., and Stevenson L.W. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 84 (1991) 40-48
6. Wolf P.A., Mitchell J.B., Baker C.S., Kannel W.B., and D'Agostino R.B. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 158 (1998) 229-234
7. Kopecky S.L., Gersh B.J., McGoon M.D., Whisnant J.P., Holmes Jr. D.R., Ilstrup D.M., et al. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 317 (1987) 669-674
8. Doval H.C., Nul D.R., Grancelli H.O., Perrone S.V., Bortman G.R., and Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 344 (1994) 493-498
9. Torp-Pedersen C., Moller M., Bloch-Thomsen P.E., Kober L., Sandoe E., Egstrup K., et al. Dofetilide in patients with congestive heart failure and LV dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med 341 (1999) 857-865
10. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316 (1987) 1429-1435
11. Hynes B.J., Luck J.C., Wolbrette D.L., Bhatta L., Khan M., Samii S., et al. Atrial fibrillation in patients with heart failure. Curr Opin Cardiol 18 (2003) 32-38
12. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1825-1833
13. Van Gelder I.C., Hagens V.E., Bosker H.A., Kingma J.H., Kamp O., Kingma T., et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002) 1834-1840
14. Francis G.S., Benedict C., Johnstone D.E., Kirlin P.C., Nicklas J., Liang C.S., et al. Comparison of neuroendocrine activation in patients with LV dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82 (1990) 1724-1729
15. Cohn J.N., Levine T.B., Olivari M.T., Garberg V., Lura D., Francis G.S., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311 (1984) 819-823
16. Floras J.S. Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities. Acta Physiol Scand 177 (2003) 391-398
17. Van den Berg M.P., Tuinenburg A.E., Van Gelder I.C., Gosselink A.T., and Lie K.I. Heart failure and atrial fibrillation: current concepts and controversies. Heart 77 (1997) 309-313
18. Doshi R.N., Wu T.J., Yashima M., Kim Y.H., Ong J.J., Cao J.M., et al. Relation between Ligament of Marshall and adrenergic atrial tachyarrhythmia. Circulation 100 (1999) 876-883
19. Kalman J.M., Munawar M., Howes L.G., Louis W.J., Buxton B.F., Gutteridge G., et al. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 60 (1995) 1709-1715
20. Carson P.E., Johnson G.R., Dunkman W.B., Fletcher R.D., Farrell L., and Cohn J.N. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. Circulation 87 6 Suppl (1993) VI102-VI110
21. Gosselink A.T., Bijlsma E.B., Landsman M.L., Crijns H.J., and Lie K.I. Long-term effect of cardioversion on peak oxygen consumption in chronic atrial fibrillation. A 2-year follow-up. Eur Heart J 15 (1994) 1368-1372
22. Moe G.W., Stopps T.P., Angus C., Forster C., De Bold A.J., and Armstrong P.W. Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure. J Am Coll Cardiol 13 (1989) 173-179
23. Sabbah H.N., Stein P.D., Kono T., Gheorghiade M., Levine T.B., Jafri S., et al. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol 260 (1991) H1379-H1384
24. Sabbah H.N., Shimoyama H., Kono T., Gupta R.C., Sharov V.G., Scicli G., et al. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of LV dysfunction and dilation in dogs with reduced ejection fraction. Circulation 89 (1994) 2852-2859
25. Dodge H.T., Sandler H., Baxley W.A., and Hawley R.R. Usefulness and limitations of radiographic methods for determining left ventricular volume. Am J Cardiol 18 (1966) 10-24
26. Ganhao M.F., Hattingh J., Hurwitz M.L., and Pitts N.I. Evaluation of a simple plasma catecholamine extraction procedure prior to high-performance liquid chromatography and electrochemical detection. J Chromatogr 564 (1991) 55-66
27. Haber E., Koerner T., Page L.B., Kliman B., and Purnode A. Application of radioimmunoassay for angiotensin I for measurement of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 29 (1969) 1349-1355
28. Armitage P., Berry G., and Matthews J.N.S. Statistical Methods in Medical Research. Ed 2. (2002), Blackwell Publishing, Malden, MA 373
29. Pozzoli M., Cioffi G., Traversi E., Pinna G.D., Cobelli F., and Tavazzi L. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 32 (1998) 197-204
30. Yamada T., Fukunami M., Shimonagata T., Kumagai K., Ogita H., Asano Y., et al. Prediction of paroxysmal atrial fibrillation in patients with congestive heart failure: a prospective study. J Am Coll Cardiol 35 (2000) 405-413
31. Roy D., Paillard F., Cassidy D., Bourassa M.G., Gutkowska J., Genest J., et al. Atrial natriuretic factor during atrial fibrillation and supraventricular tachycardia. J Am Coll Cardiol 9 (1987) 509-514
32. Berglund H., Boukter S., Theodorsson E., Vallin H., and Edhag O. Raised concentrations of atrial natriuretic peptide are independent of left atrial dimensions in patients with chronic atrial fibrillation. Br Heart J 64 (1990) 9-13
33. Rossi A., Enriquez-Sarano M., Burnett Jr. J.C., Lerman A., Abel M.D., and Seward J.B. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol 35 (2000) 1256-1262
34. Gould P.A., Esler M.D., and Kaye D.M. Chronic atrial fibrillation does not influence the magnitude of sympathetic overactivity in patients with heart failure. Eur Heart J 24 (2003) 1657-1662
35. Jayachandran J.V., Sih H.J., Winkle W., Zipes D.P., Hutchins G.D., and Olgin J.E. Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. Circulation 101 (2000) 1185-1191
36. Burchell S.A., Spinale F.G., Crawford F.A., Tanaka R., and Zile M.R. Effects of chronic tachycardia-induced cardiomyopathy on the beta-adrenergic receptor system. J Thorac Cardiovasc Surg 104 (1992) 1006-1012
37. Spinale F.G., Tempel G.E., Mukherjee R., Eble D.M., Brown R., Vacchiano C.A., et al. Cellular and molecular alterations in the beta adrenergic system with cardiomyopathy induced by tachycardia. Cardiovasc Res 28 (1994) 1243-1250